Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 162

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Noncanonical Wnt Signaling Promotes Obesity-Induced Adipose Tissue Inflammation and Metabolic Dysfunction Independent of Adipose Tissue Expansion

Open access
Fuster, José J., Zuriaga, María A., Ngo, Doan Thi-Minh, Farb, Melissa G., Aprahamian, Tamar, Yamaguchi, Terry P., Gokce, Noyan, Walsh, Kenneth · 2015 · Diabetes

Abstract

Adipose tissue dysfunction plays a pivotal role in the development of insulin resistance in obese individuals. Cell culture studies and gain-of-function mouse models suggest that canonical Wnt proteins modulate adipose tissue expansion. However, no genetic evidence supports a role for endogenous Wnt proteins in adipose tissue dysfunction, and the role of noncanonical Wnt signaling remains largely unexplored. Here we provide evidence from human, mouse, and cell culture studies showing that Wnt5a-mediated, noncanonical Wnt signaling contributes to obesity-associated metabolic dysfunction by increasing adipose tissue inflammation. Wnt5a expression is significantly upregulated in human visceral fat compared with subcutaneous fat in obese individuals. In obese mice, Wnt5a ablation ameliorates insulin resistance, in parallel with reductions in adipose tissue inflammation. Conversely, Wnt5a overexpression in myeloid cells augments adipose tissue inflammation and leads to greater impairments in glucose homeostasis. Wnt5a ablation or overexpression did not affect fat mass or adipocyte size. Mechanistically, Wnt5a promotes the expression of proinflammatory cytokines by macrophages in a Jun NH2-terminal kinase–dependent manner, leading to defective insulin signaling in adipocytes. Exogenous interleukin-6 administration restores insulin resistance in obese Wnt5a-deficient mice, suggesting a central role for this cytokine in Wnt5a-mediated metabolic dysfunction. Taken together, these results demonstrate that noncanonical Wnt signaling contributes to obesity-induced insulin resistance independent of adipose tissue expansion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db14-1164

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 67

  1. Neeland, 2012, Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults, JAMA, 308, 1150, 10.1001/2012.jama.11132 · DOI · Paper page
  2. Boyko, 2000, Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans, Diabetes Care, 23, 465, 10.2337/diacare.23.4.465 · DOI · Paper page
  3. Preis, 2010, Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study, Obesity (Silver Spring), 18, 2191, 10.1038/oby.2010.59 · DOI · Paper page
  4. McLaughlin, 2011, Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity, J Clin Endocrinol Metab, 96, E1756, 10.1210/jc.2011-0615 · DOI · Paper page
  5. Porter, 2009, Abdominal subcutaneous adipose tissue: a protective fat depot?, Diabetes Care, 32, 1068, 10.2337/dc08-2280 · DOI · Paper page
  6. Snijder, 2005, Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study, Diabetologia, 48, 301, 10.1007/s00125-004-1637-7 · DOI · Paper page
  7. Farb, 2012, Arteriolar function in visceral adipose tissue is impaired in human obesity, Arterioscler Thromb Vasc Biol, 32, 467, 10.1161/ATVBAHA.111.235846 · DOI
  8. Adams, 1997, Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation, J Clin Invest, 100, 3149, 10.1172/JCI119870 · DOI · Paper page
  9. Tchkonia, 2002, Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes, Am J Physiol Regul Integr Comp Physiol, 282, R1286, 10.1152/ajpregu.00653.2001 · DOI · Paper page
  10. Tchkonia, 2006, Fat depot-specific characteristics are retained in strains derived from single human preadipocytes, Diabetes, 55, 2571, 10.2337/db06-0540 · DOI · Paper page
  11. Gesta, 2006, Evidence for a role of developmental genes in the origin of obesity and body fat distribution, Proc Natl Acad Sci U S A, 103, 6676, 10.1073/pnas.0601752103 · DOI · Paper page
  12. Yamamoto, 2010, Adipose depots possess unique developmental gene signatures, Obesity (Silver Spring), 18, 872, 10.1038/oby.2009.512 · DOI · Paper page
  13. Vohl, 2004, A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men, Obes Res, 12, 1217, 10.1038/oby.2004.153 · DOI · Paper page
  14. Logan, 2004, The Wnt signaling pathway in development and disease, Annu Rev Cell Dev Biol, 20, 781, 10.1146/annurev.cellbio.20.010403.113126 · DOI · Paper page
  15. Christodoulides, 2009, Adipogenesis and WNT signalling, Trends Endocrinol Metab, 20, 16, 10.1016/j.tem.2008.09.002 · DOI · Paper page
  16. Bennett, 2002, Regulation of Wnt signaling during adipogenesis, J Biol Chem, 277, 30998, 10.1074/jbc.M204527200 · DOI · Paper page
  17. Ross, 2000, Inhibition of adipogenesis by Wnt signaling, Science, 289, 950, 10.1126/science.289.5481.950 · DOI · Paper page
  18. Cawthorn, 2012, Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism, Bone, 50, 477, 10.1016/j.bone.2011.08.010 · DOI · Paper page
  19. Wright, 2007, Wnt10b inhibits obesity in ob/ob and agouti mice, Diabetes, 56, 295, 10.2337/db06-1339 · DOI · Paper page
  20. Longo, 2004, Wnt10b inhibits development of white and brown adipose tissues, J Biol Chem, 279, 35503, 10.1074/jbc.M402937200 · DOI · Paper page
  21. Halleskog, 2012, Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation, J Neuroinflammation, 9, 111, 10.1186/1742-2094-9-111 · DOI
  22. Blumenthal, 2006, The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation, Blood, 108, 965, 10.1182/blood-2005-12-5046 · DOI · Paper page
  23. Rauner, 2012, WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production, J Bone Miner Res, 27, 575, 10.1002/jbmr.1488 · DOI
  24. Pereira, 2008, Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10, Arterioscler Thromb Vasc Biol, 28, 504, 10.1161/ATVBAHA.107.157438 · DOI · Paper page
  25. Pukrop, 2006, Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines, Proc Natl Acad Sci U S A, 103, 5454, 10.1073/pnas.0509703103 · DOI · Paper page
  26. Miyoshi, 2012, Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury, Science, 338, 108, 10.1126/science.1223821 · DOI · Paper page
  27. Yamaguchi, 1999, A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo, Development, 126, 1211, 10.1242/dev.126.6.1211 · DOI · Paper page
  28. Zhao, 2013, SFRP5 inhibits gastric epithelial cell migration induced by macrophage-derived Wnt5a, Carcinogenesis, 34, 146, 10.1093/carcin/bgs309 · DOI
  29. Bilkovski, 2011, Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans, Int J Obes (Lond), 35, 1450, 10.1038/ijo.2011.6 · DOI
  30. Katoh, 2009, Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades, Int J Mol Med, 23, 763, 10.3892/ijmm_00000190 · DOI · Paper page
  31. Ge, 2011, Requirement of the NF-κB pathway for induction of Wnt-5A by interleukin-1β in condylar chondrocytes of the temporomandibular joint: functional crosstalk between the Wnt-5A and NF-κB signaling pathways, Osteoarthritis Cartilage, 19, 111, 10.1016/j.joca.2010.10.016 · DOI
  32. Glass, 2012, Inflammation and lipid signaling in the etiology of insulin resistance, Cell Metab, 15, 635, 10.1016/j.cmet.2012.04.001 · DOI · Paper page
  33. Nomachi, 2008, Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A, J Biol Chem, 283, 27973, 10.1074/jbc.M802325200 · DOI · Paper page
  34. Oishi, 2003, The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway, Genes Cells, 8, 645, 10.1046/j.1365-2443.2003.00662.x · DOI · Paper page
  35. Yamanaka, 2002, JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates, EMBO Rep, 3, 69, 10.1093/embo-reports/kvf008 · DOI · Paper page
  36. Schambony, 2007, Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway, Dev Cell, 12, 779, 10.1016/j.devcel.2007.02.016 · DOI · Paper page
  37. Han, 2013, JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation, Science, 339, 218, 10.1126/science.1227568 · DOI · Paper page
  38. Permana, 2006, Macrophage-secreted factors induce adipocyte inflammation and insulin resistance, Biochem Biophys Res Commun, 341, 507, 10.1016/j.bbrc.2006.01.012 · DOI · Paper page
  39. Prats-Puig, 2014, Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children, Pediatr Res, 75, 793, 10.1038/pr.2014.29 · DOI
  40. Catalán, 2014, Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation, J Clin Endocrinol Metab, 99, E1407, 10.1210/jc.2014-1191 · DOI
  41. Masckauchán, 2006, Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2, Mol Biol Cell, 17, 5163, 10.1091/mbc.e06-04-0320 · DOI · Paper page
  42. Bilkovski, 2010, Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes, J Biol Chem, 285, 6170, 10.1074/jbc.M109.054338 · DOI
  43. Kim, 2010, Wnt5a induces endothelial inflammation via beta-catenin-independent signaling, J Immunol, 185, 1274, 10.4049/jimmunol.1000181 · DOI · Paper page
  44. Oderup, 2013, Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance, J Immunol, 190, 6126, 10.4049/jimmunol.1203002 · DOI
  45. Valencia, 2011, Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features, J Immunol, 187, 4129, 10.4049/jimmunol.1101243 · DOI
  46. Bergenfelz, 2012, Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients, J Immunol, 188, 5448, 10.4049/jimmunol.1103378 · DOI
  47. Schaale, 2011, Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses, Eur J Cell Biol, 90, 553, 10.1016/j.ejcb.2010.11.004 · DOI · Paper page
  48. Malhotra, 2009, Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells, Exp Hematol, 37, 19, 10.1016/j.exphem.2008.08.008 · DOI
  49. Manicassamy, 2010, Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine, Science, 329, 849, 10.1126/science.1188510 · DOI · Paper page
  50. Neumann, 2010, Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages, FASEB J, 24, 4599, 10.1096/fj.10-160994 · DOI
  51. Ouchi, 2010, Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity, Science, 329, 454, 10.1126/science.1188280 · DOI · Paper page
  52. Li, 2008, Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling, Genes Dev, 22, 3050, 10.1101/gad.1687308 · DOI · Paper page
  53. Mori, 2012, Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition, J Clin Invest, 122, 2405, 10.1172/JCI63604 · DOI · Paper page
  54. Wada, 2013, Selective modulation of Wnt ligands and their receptors in adipose tissue by chronic hyperadiponectinemia, PLoS ONE, 8, e67712, 10.1371/journal.pone.0067712 · DOI
  55. Nishizuka, 2008, Wnt4 and Wnt5a promote adipocyte differentiation, FEBS Lett, 582, 3201, 10.1016/j.febslet.2008.08.011 · DOI
  56. van Tienen, 2009, Wnt5b stimulates adipogenesis by activating PPARgamma, and inhibiting the beta-catenin dependent Wnt signaling pathway together with Wnt5a, Biochem Biophys Res Commun, 387, 207, 10.1016/j.bbrc.2009.07.004 · DOI
  57. Laudes, 2011, Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes, J Mol Endocrinol, 46, R65
  58. Takada, 2007, A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation, Nat Cell Biol, 9, 1273, 10.1038/ncb1647 · DOI · Paper page
  59. Ishitani, 2003, The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling, Mol Cell Biol, 23, 131, 10.1128/MCB.23.1.131-139.2003 · DOI · Paper page
  60. Di Gregorio, 2004, Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity, Am J Physiol Endocrinol Metab, 287, E182, 10.1152/ajpendo.00189.2003 · DOI · Paper page
  61. Klover, 2005, Interleukin-6 depletion selectively improves hepatic insulin action in obesity, Endocrinology, 146, 3417, 10.1210/en.2004-1468 · DOI · Paper page
  62. Bastard, 2002, Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro, J Clin Endocrinol Metab, 87, 2084, 10.1210/jcem.87.5.8450 · DOI · Paper page
  63. Vozarova, 2001, Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion, Obes Res, 9, 414, 10.1038/oby.2001.54 · DOI · Paper page
  64. Pradhan, 2001, C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327 · DOI · Paper page
  65. Bashan, 2007, Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity, Endocrinology, 148, 2955, 10.1210/en.2006-1369 · DOI
  66. Cartier, 2008, Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men, J Clin Endocrinol Metab, 93, 1931, 10.1210/jc.2007-2191 · DOI · Paper page
  67. Park, 2005, Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6, Diabetes Res Clin Pract, 69, 29, 10.1016/j.diabres.2004.11.007 · DOI · Paper page

Cited by

See all 162

Metadata

Authors
Fuster, J. J., Zuriaga, M. A., Ngo, D. T.-M., Farb, M. G., Aprahamian, T., Yamaguchi, T. P., Gokce, N., & Walsh, K.
Venue
Diabetes
Published
2014-10-28
Volume
64
Issue
4
Pages
1235-1248
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2165379056
Cited by
162
References
15
FWCI
8.31
Type
journal article
Language
en
Open access
green
Funders
  • American Heart Association (12POST11780028)
  • National Institutes of Health (AG034972, HL081587, HL084213, HL1145675, HL116591, HL120160, HL68758, P30DK046200, UL1RR025771)
  • Ramon Areces Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.